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Abstract 
Methadone appears to be a promising candidate for pain management. Previously, we 
conducted a comprehensive characterization study of methadone base and evaluated the dermal 
delivery of methadone from various neat solvents. Four solvents, namely d-limonene (LIM), 
ethyl oleate (EO), Transcutol® P (TC) and octyl salicylate (OSAL), were identified as the 
optimal neat solvents for skin delivery of the compound. To explore further approaches to 
improve methadone permeation, the present work investigated a range of binary and ternary 
vehicles. In vitro permeation studies in porcine skin confirmed that binary systems delivered 
significantly higher (p < 0.05) amounts of methadone through the skin compared with neat 
solvents. The highest skin permeation was observed for formulations composed of propylene 
glycol (PG) and TC. Nine formulations were subsequently examined in human skin. A good 
correlation (r2 = 0.80) for methadone permeation was obtained between porcine ear skin and 
human skin data. Solvent uptake studies indicated that the presence of PG not only increased 
methadone permeation but also TC permeation. The drug appears to “track” the permeation of 
TC. Future studies will expand further the range of potential vehicles for optimal delivery of 
the drug, that will ultimately to be investigated in clinical studies. 
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2Abbreviations:
NMDA N-methyl-D-aspartate
LIM d-limonene 
EO Ethyl oleate
TC Transcutol® P
OSAL Octyl salicylate
IPA Isopropyl alcohol
PG Propylene glycol
HPLC High performance liquid chromatography
OA Oleic acid
PGML Propylene glycol monolaurate 
WL 1349 Labrafac™ lipophile WL 1349
PBS Phosphate buffered saline
DVS Dynamic vapor sorption
RH Relative humidity
GC Gas chromatography
FID Flame ionization detector
LOD Limit of detection
LOQ Limit of quantification
ICH International Conference of Harmonization
OECD Organisation for Economic Co-operation and Development
SD Standard deviation 
ANOVA One-way analysis of variance
TriPG Tripropylene glycol
31. Introduction 
Methadone is not only a potent synthetic μ-opioid receptors agonist but also a non-
competitive N-methyl-D-aspartate (NMDA) receptor antagonist (McLean and Twomey, 2015). 
The use of methadone for pain management has received great interest in recent years. The 
rationale for dermal delivery of methadone has been described previously (Kung et al., 2019). 
Although topical/transdermal delivery offers advantages over other routes, the formidable 
barrier properties of the skin limit the percutaneous absorption of many active ingredients and 
subsequently their therapeutic effects. Our previous studies reported a comprehensive 
characterization of methadone free base and its hydrochloride salt and suggested that the free 
base form of methadone has more favourable properties for skin permeation compared with 
the salt form. A range of vehicles, spanning different physicochemical parameters were also 
tested. The results for finite dose permeation studies indicated that d-limonene (LIM), ethyl 
oleate (EO), Transcutol® P (TC) and octyl salicylate (OSAL) were the optimal solvents for skin 
delivery of the compound (Kung et al., 2019). 
The combination of multiple solvents may also have potential for synergistic effects on 
skin delivery, especially when combining solvents with different mechanisms of penetration 
enhancement. Binary and ternary systems composed of two or three solvents have been 
investigated by a number of researchers for  dermal delivery of actives (Brinkmann and Müller-
Goymann, 2005; Mohammed et al., 2014; Parisi et al., 2016; Haque et al., 2018; Zhang et al., 
2019a; Iliopoulos et al., 2020). Recently, Zhang et al. (2019a) reported the permeation of 
niacinamide from a range of binary and ternary formulations in porcine skin, human skin and 
an artificial membrane. Enhanced skin delivery was observed for binary and ternary systems 
compared with single solvents. For example, the inclusion of oleic acid or linolenic acid with 
propylene glycol (PG) resulted in a ~50-fold increase in the cumulative amount of niacinamide 
that permeated through human skin after 24 h compared with neat PG. Although co-solvent 
systems have been explored in this and other studies, the effects of such systems on the skin 
delivery of methadone have not been reported to date.
Depletion of solvents from the skin surface via either skin permeation or evaporation 
may alter the thermodynamic activity and, subsequently, permeation of active ingredients. 
Therefore, monitoring of formulation components should provide insights into how topical 
products may be better formulated. To our knowledge, PG permeation in human skin was first 
reported by Hoelgaard and Mollgaard (1985). The authors found a positive relationship 
between the degree of PG permeation and metronidazole permeation. A “carrier-solvent” effect 
was therefore proposed by the authors. However, few studies to date have monitored skin 
4permeation of both active ingredient and vehicle and focus rather on analysing the active 
ingredients alone. Oliveira et al. (2012) investigated the uptake of isopropyl myristate, 
dimethyl isosorbide and TC in human skin. The authors suggested that high solvent uptake 
promoted the stratum corneum partitioning of methyl paraben by modifying the solubility 
characteristics of the molecule in the skin. More recently, Haque et al. (2017) reported 
permeation profiles of both anthramycin and four neat solvents, namely PG, 1,3-butanediol 
(BD), dipropylene glycol and TC. The highest permeation of both solvent and anthramycin 
through human skin was observed for TC, followed by PG. The authors suggested that 
anthramycin permeation appeared to “track” the permeation of TC and PG. Subsequently, the 
same authors reported the effects of binary and ternary systems on the permeation of both 
anthramycin and solvents (Haque et al., 2018). The inclusion of 10% propylene glycol 
monocaprylate or propylene glycol monolaurate increased the permeation of both PG and 
anthramycin compared with using neat PG. This suggests that formulation composition can not 
only affect the permeation of an active ingredient but also the permeation of the vehicle 
components themselves. The aims of this study were therefore (i) to investigate binary and 
ternary vehicles for the dermal delivery of methadone free base in porcine skin (ii) to 
investigate any synergistic effects on human skin permeation for binary and ternary 
formulations (iii) to determine the skin uptake and permeation interdependence of both active 
and selected solvents.  
2. Materials and methods
2.1. Materials
Methadone hydrochloride, tripropylene glycol (TriPG), Brij™ O20, OSAL and 
isopropyl alcohol (IPA) were purchased from Sigma-Aldrich (U.K.). PG, LIM, high 
performance liquid chromatography (HPLC) grade water, acetonitrile, orthophosphoric acid, 
85+%, sodium dihydrogen phosphate and sodium hydrogen phosphate were supplied by Fisher 
Scientific (U.K.). Oleic acid (OA) and EO were provided by Fluka (U.K.). Labrafac™ lipophile 
WL 1349 (medium-chain triglycerides of caprylic and capric acids, WL 1349), TC and 
propylene glycol monolaurate (PGML) Type II were gifts from Gattefossé (St. Priest, France). 
Phosphate buffered saline (PBS) (pH 7.3 ± 0.2 at 25 °C) was prepared using Dulbecco A tablets 
supplied by Oxoid (U.K.). Porcine tissue was obtained from a local abattoir on the day of 
slaughter. Abdominal human skin (Caucasian female donor) was obtained from a tissue bank 
with institutional ethical approval (Research Ethics Committee reference 07/H1306/98).
52.2. Dynamic vapor sorption (DVS) studies
Dynamic vapor sorption analysis was conducted with a Q5000 SA sorption analyzer 
(TA Instruments, U.S.A.). The instrument is equipped with an autosampler, a humidity control 
chamber and a microbalance, allowing accuracy and precision in weight-change detection 
(accurate to 0.0001 mg). Nitrogen with a flow rate at 200 mL/min was used as the purge gas 
for the humidity control chamber. The relative humidity (RH) and temperature of the humidity 
chamber were set to 50 % and 32 °C prior to each experiment. Approximately 5 mg of sample 
was added into a metal coated quartz pan, placed in the humidity control chamber. The mass 
change of each sample was monitored over 24 h.
2.3. Gas chromatography (GC) analysis
The GC system used in this study was an Agilent 7890A (G3440A) GC system, 
equipped with a G4513A autosampler and a flame ionization detector (FID) (Agilent 
Technologies, U.S.A.). Analysis was performed with a capillary GC column L×I.D. 30 m×0.32 
mm with a 0.25 µm stationary phase HP 5® [(5%-Phenyl)-methyl polysiloxane] (Agilent J & 
W GC column, U.S.A.). Data were collected and analyzed with OpenLAB CDS ChemStation 
® Edition Rev C.01.04 (Agilent Technologies, U.S.A.). Nitrogen was used as the carrier gas at 
a flow rate of 2 mL/min. The inlet temperature and purge flow were set to 250 °C and 40 
mL/min at 0.75 min, respectively. 5 μL of sample was injected in the splitless mode. The 
detector temperature was set at 325 °C. The initial oven temperature was set at 50 °C, ramped 
to 80 °C at 10 °C/min, held at 80 °C for 2 min, then ramped to 100 °C at 10 °C/min, held at 
100 °C for 4 min, and finally ramped to 300 °C at 80 °C/min and held at 300 °C for 8 min. The 
GC method was validated in terms of specificity, linearity, accuracy, precision, limit of 
detection (LOD) and limit of quantification (LOQ) according to the International Conference 
of Harmonization (ICH) guidelines Q2 (R1) (ICH, 2005). Calibration curves for PG and TC 
within the concentration range of 0.04 – 1 μL/mL were constructed (r2 ≥ 0.99) and the LOQ 
values for PG and TC were 0.09 and 0.08 µL/mL, respectively.
2.4. HPLC analysis
The HPLC method for the analysis of methadone has been reported previously by Kung 
et al. (2019). The method was validated following ICH guidelines Q2 (R1) (ICH, 2005). 
Calibration curves for methadone within the concentration range of 0.5–100 μg/mL were 
constructed (r2 ≥ 0.99) with the LOQ of 0.69 µg/mL.
62.5. In vitro finite dose permeation and mass balance studies
Full-thickness porcine ear skin was separated from the cartilage while the excised 
epidermis of human skin was prepared by the heat separation method (Kligman and 
Christophers, 1963). The skin was stored at −20 °C until required. In vitro permeation studies 
were conducted according to the Organisation for Economic Co-operation and Development 
(OECD) guideline No. 428 (OECD, 2004a) using custom-made vertical glass Franz diffusion 
cells (Soham Scientific, U.K.). Details have also been reported previously by Santos et al. 
(2010). The diffusion area was ~1 cm2 and was accurately measured using a Vernier Callipers 
(Fisher Scientific, U.K.). PBS pH 7.3 ± 0.2 with the addition of 6% w/v Brij™ O20 was used 
as the receptor medium to ensure sink conditions during permeation studies (Bronaugh and 
Stewart, 1984; Brain et al., 2002). The receptor compartment was filled with ~ 2.1 mL of the 
receptor medium. Finite doses (5 μL/cm2) of 5% w/v methadone base formulations were 
applied. Permeation studies were conducted over 24 h at 32 ± 1 °C. The receptor medium was 
sampled at 0, 2, 4, 6, 8, 10, 12, 24 h after the formulation application. Mass balance studies 
were validated and conducted after each permeation study as reported previously as described 
by Kung et al. (2019). Samples from permeation and mass balance studies were analyzed by 
HPLC and GC.
2.6. Statistical analysis
Data processing and the calculation of mean and standard deviation (SD) were 
determined using Microsoft Excel® 2016 (Microsoft, U.S.A.). Statistical analysis was 
performed using IBM® SPSS Statistics® 24.0 (IBM SPSS Statistics, U.K.). The normality of 
the data was assessed using the Shapiro-Wilk test. For the parametric data that were assumed 
to be normally distributed, the independent-sample t test and one-way analysis of variance 
(ANOVA) with Tukey’s HSD post hoc test were used to analyze two groups and ≥3 groups 
respectively. For the non-parametric data (non-normally distributed data), the Mann-Whitney 
U test was used to test statistical significance between two groups and the Kruskal-Wallis one-
way ANOVA test was performed to investigate statistical differences between different groups 
(≥ 3 groups). A p-value lower than 0.05 was considered as a statistically significant difference.
3. Results and discussion 
3.1. Formulation evaporation studies using DVS
If a solvent component of a drug solution evaporates after application, it will potentially 
increase the concentration of the active on the skin surface. Eight solvents that we have 
7investigated in our previous skin permeation studies were selected to evaluate their volatility. 
The results for formulation evaporation studies under static conditions (32 ± 1 °C and 50 ± 1.5% 
RH) are shown in Figure 1. The weight of TC and TriPG increased during the first 15 min 
because of the hygroscopic nature of these solvents. LIM evaporated completely by 45 min 
with approximately 5% of the applied mass remaining, namely the residual methadone free 
base, in the sample pan. The steady-state evaporation rates of LIM and TC were 84.37 ± 1.13 
and 5.10 ± 0.42 μg/min, respectively. Less than 2 % of the applied PGML, TriPG, OSAL, EO, 
OA and WL1349 formulations evaporated over 24 h. The results for TC, PGML and OSAL 
were consistent with previous studies (Haque et al., 2017; Paz-Alvarez et al., 2018). 
3.2. In vitro finite dose permeation and mass balance studies
3.2.1. Binary systems in porcine skin
In our previous methadone permeation studies on single solvent systems, LIM, EO, TC 
and OSAL appeared to be promising candidate components of dermal formulations for 
methadone delivery. PG is extensively used in dermal formulations and the Cosmetic 
Ingredient Review Expert Panel has concluded that PG is safe as used in cosmetic formulations 
(Fiume et al., 2012). A number of studies have reported the use of PG for skin delivery of 
actives (Barrett et al., 1965; Poulsen et al., 1968; Coldman et al., 1969; Davis et al., 1981; 
Hoelgaard and Mollgaard, 1985; Kasting et al., 1993; Arellano et al., 1999; Trottet et al., 2004; 
Nicolazzo et al., 2005; Watkinson et al., 2009; Zhang et al., 2011). However, neat PG was not 
taken forward for investigation because of the low solubility of methadone free base in PG 
(24.78± 0.49 mg/mL at 32 ± 1 °C). TC was used to increase the solubility of methadone in 
formulations containing PG (solubility data are shown in Figure S1). A binary PG:TC system 
was therefore selected in order to investigate the effects of PG and TC on methadone 
permeation. 
The cumulative amounts of methadone that permeated through porcine skin from 
binary systems are shown in Figure 2 and the mass balance results are summarized in Table 
S1. Previous studies with neat solvents confirmed that LIM delivered the highest amount of 
methadone through porcine skin (Kung et al., 2019). The results from the present work show 
that, with the exception of the EO/OSAL formulation, the binary formulations delivered 
significantly higher (p < 0.05) amounts of methadone through porcine skin compared with LIM. 
The percentages of applied methadone remaining on the skin surface ranged from 15.33% to 
46.03%. In addition, the highest permeation of methadone observed was 161.01 ± 19.66 μg/cm2 
(73.74 ± 8.15% of applied dose) for the PG:TC (50:50) formulation after 24 h, significantly 
8higher than other formulations presented in Figure 2 (p < 0.01). The PG:TC (50:50) formulation 
promoted a 40-fold increase in the cumulative amount of methadone that permeated through 
porcine skin at 12 h compared with neat TC. 
To investigate further the roles of PG and TC for formulation optimization, various 
ratios of PG:TC from 25:75 to 75:25 were selected for permeation and mass balance studies 
(data are shown in Figure. 3 and Table S1). Both PG:TC (25:75) and PG:TC (50:50) appear to 
be promising vehicles for methadone free base and no significant difference (p > 0.05) was 
observed between the permeation values. PG:TC (25:75) delivered 152.07 ± 26.20 μg/cm2 of 
methadone through porcine skin after 24 h. The pseudo steady state skin fluxes for PG:TC 
(25:75) and PG:TC (50:50) were 10.01 ± 2.81 and 13.11 ± 2.60 μg/cm2/h, respectively. These 
values were significantly higher (p < 0.01) than the maximum value (2.54 ± 0.19 μg/cm2/h) 
obtained for the single solvent systems. However, the percentage of applied methadone that 
permeated through skin for PG:TC (75:25) was significantly lower compared with other PG/TC 
binary formulations (p < 0.01). One reason for this result is that drug crystallization occurred. 
Methadone crystals were found on the skin surface during permeation (Figure S1). When the 
depletion of solvents from skin surface (via skin uptake or evaporation) is far greater than that 
for methadone, drug crystallization may occur, notably for PG:TC (75:25) where the solubility 
of methadone is relatively low (Figure S2). Results from mass balance studies are consistent 
with these findings (Table S1). 18% and 15% of the applied dose of methadone remained on 
the skin surface for PG:TC (25:75) and PG:TC (50:50), respectively, while 48% of the applied 
dose of methadone from PG:TC (75:25) remained on the skin surface. The total recovery values 
for all binary formulations were within the recovery range (90% – 110%) recommended by the 
relevant OECD guidelines (OECD, 2004b).
3.2.2. Ternary systems in porcine skin
Ternary systems composed of PG, TC and IPA or LIM were also evaluated and the 
permeation profiles are shown in Figure 4. The cumulative amounts of methadone that 
permeated through porcine skin for PG:TC:IPA (40:40:20) and PG:TC:IPA (30:30:40) were 
significantly higher (p < 0.01) than for the single solvent systems. The pseudo steady state skin 
fluxes for PG:TC:IPA (40:40:20) and PG:TC:IPA (30:30:40) were 11.98 ± 2.89 and 8.23 ± 
0.90 μg/cm2/h, respectively. Results of the mass balance studies for ternary formulations are 
shown in Table S1. The percentages of methadone recovered from skin extraction for 
PG/TC/IPA ternary formulations were significantly higher (p < 0.05) compared with PG:TC 
(50:50). The concentrations of TC in PG/TC/IPA ternary formulations were relatively lower 
9compared with the PG:TC (50:50) formulation. Methadone permeation may be influenced by 
the depletion of TC in the skin. This might explain why the PG/TC/IPA ternary formulations 
delivered low (p < 0.05) amounts of methadone through the skin compared with PG:TC (50:50).
Although LIM is generally recognized as a safe ingredient in topical products (Herman 
and Herman, 2015), the highest concentration that has been used in FDA approved topical 
products is 10% w/w (FDA, 2018). Therefore,  only 5% w/v of LIM was incorporated in the 
PG/TC/LIM ternary formulations. There was no significant difference (p > 0.05) in the 
cumulative amounts of permeation of methadone for PG:TC (50:50), PG:TC:LIM (45:50:5) 
and PG:TC:LIM (65:30:5). In contrast, the permeation of methadone for the PG:TC:LIM 
(25:70:5) formulations was significantly lower (p < 0.05) compared with the PG/TC/LIM 
ternary formulations containing higher concentrations of PG. This suggests that the dose of PG 
may play an important role in enhancing permeation of methadone as reported for loperamide 
by  Trottet et al. (2004). Although the PG dose-dependent effect for PG/TC binary systems was 
not observed in porcine skin, this effect was observed in human skin (see Figure 5 below in 
Section 3.2.3). Methadone permeation from PG:TC (50:50) 24h post application in human skin 
was significantly higher (p < 0.01) compared with PG:TC (25:75). One possible reason why 
no statistically significant difference between PG:TC (25:75) and PG:TC (50:50) was observed 
in porcine skin is that the effect may be “masked” by the variability of porcine skin 
permeability.
3.2.3. Single, binary and ternary systems in human skin
To confirm the synergistic action of binary and ternary systems, some of the 
formulations that were tested in porcine skin were also evaluated in human skin. The results of 
the permeation and mass balance studies are shown in Figure. 5 and Table S2, respectively. A 
synergistic action of PG and TC was observed and PG:TC (50:50) delivered the highest amount 
(p < 0.05) of methadone through skin after 24 h compared with other formulations tested in 
human skin. Unlike permeation studies in porcine skin, the finite dose permeation profiles in 
human skin did not show a classic plateau for most formulations, with the exception of 
PG/TC/IPA systems. It is notable that the PG:TC:IPA system delivered significantly higher (p 
< 0.05) amounts of methadone through human skin than the PG:TC (50:50) formulation up to 
12 h. Compared with TC, an 8.9-fold increase in the cumulative amount of methadone that 
permeated at 12 h was observed for PG:TC (50:50) while a 21.5-fold increase was observed 
for PG:TC:IPA (40:40:20). After 12 h, a plateau for methadone permeation was observed for 
PG:TC:IPA (40:40:20) and PG:TC:IPA (30:30:40) that may reflect the depletion of methadone. 
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Rapid clearance of vehicles may also lead to this plateau when vehicle permeation is far faster 
than methadone, which would result in methadone crystallization in the skin. Further 
permeation of methadone was therefore limited. This might explain why relatively high 
deposition of methadone in the skin was observed for PG:TC:IPA (30:30:40) in mass balance 
studies (Table S2).  For an analgesic, predictable rates of absorption and time to known steady 
state plasma or tissue levels will be required for efficacy in clinical use. The lag times of 
methadone permeation for PG:TC (50:50) and PG:TC:IPA (40:40:20) were 6.55 ± 0.32 h and 
3.59 ± 0.21 h, respectively. This indicates that the inclusion of a volatile solvent in PG/TC 
binary formulations may be a favourable strategy for dermal delivery of methadone. Patients 
may benefit from the shorter lag time and relatively high amounts of methadone permeation 
within 12 h post application.
3.3. Correlation of methadone permeation in porcine skin and human skin
The relationship between methadone permeation in porcine skin and human skin is 
shown in Figure 6. The results confirm that, for methadone, porcine skin is 2-5 times more 
permeable than human skin, which is consistent with previous studies (Dick and Scott, 1992; 
Singh et al., 2002; Boudry et al., 2008; Vallet et al., 2008; Zhang et al., 2019b). A positive 
correlation between the cumulative amount of methadone permeation in porcine ear skin and 
human skin was observed (r2 = 0.80) in this study. This confirms the utility of porcine ear skin 
for preliminary studies to optimize methadone formulations.  
3.4. Investigation of the synergistic action of PG and TC – skin permeation of PG and TC
The human skin absorption and permeation of TC and PG were reported recently by 
our group  (Haque et al., 2017; Haque et al., 2018). In the present work the percentages of 
applied TC and PG that permeated through porcine skin and human skin are shown in Figure 
7. The percentage of PG that permeated through porcine ear skin after 24 h was significantly 
higher (p < 0.01) compared with permeation through human skin. More than 50% of the applied 
PG permeated from PG:TC binary systems through porcine skin while less than 15% of applied 
PG permeated through human skin. Rapid uptake of TC was observed for both porcine skin 
and human skin. 65-70% of TC permeated through porcine skin from the PG:TC binary 
formulations after 24 h while only 31% of TC permeated from the neat TC solution. This 
indicates that the presence of PG in formulations may facilitate the permeation of TC; a similar 
trend was also observed in human skin.  At 24 h, the values for percentage permeation of TC 
through human skin for PG:TC (25:75) and PG:TC (50:50) were 32% and 51% respectively 
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while the corresponding value for neat TC was only 13%. 
The synergistic action of PG with other vehicles on skin permeation has previously 
been observed (Haque et al., 2018; Zhang et al., 2019a; Iliopoulos et al., 2020). These finite 
dose studies reported that permeation enhancement was achieved by combining PG with 
lipophilic solvents such as isopropyl myristate, oleic acid, linolenic acid and propylene glycol 
monolaurate. The mechanism for the synergistic actions of PG with TC remains to be 
elucidated. Although synergistic actions between PG and TC on penetration enhancement have 
not been detailed in research articles, two patents assigned to Antares Pharma include pertinent 
data. US8980309 B2 disclosed the use of PG and TC at different ratios to inhibit testosterone 
crystallization in gel formulations (Carrara and Grenier, 2015). In vitro porcine skin permeation 
studies were also reported in the patent. The gels containing 5% w/w TC and 6-30% w/w PG 
led to increases in the skin permeation and skin extraction of testosterone compared with the 
control formulation after 24 h permeation studies. However, the mechanisms of synergistic 
actions from the combined use of PG and TC were not reported in the patent. US20150005337 
A1 reported that hydroalcoholic solutions containing PG and TC delivered increased amounts 
of various central nervous system acting drugs such as rivastigmine and fentanyl through 
porcine skin compared with controls (Carrara et al., 2015). The control hydroalcoholic 
solutions consisted primarily of an active ingredient, ethanol, water, pH adjusters and 
hydroxypropyl cellulose. In vitro permeation studies described in this patent have confirmed 
synergistic effects from the PG and TC with fatty alcohols such as myristyl alcohol and lauryl 
alcohol. The results from the present work are consistent with these patent disclosures. 
The mechanisms of penetration enhancement of PG have been reviewed by Lane (2013). 
The incorporation of PG into the polar regions of the lipid bilayers may modify the physical 
and chemical properties of the intercellular lipids and thus enhance the skin permeation of TC 
and methadone. Bouwstra et al. (1991) compared the arrangement of the lipid bilayers in PG 
pre-treated and untreated human stratum corneum using small-angle X-ray scattering. The 
authors suggested that PG may not lead to the swelling of lipid bilayers because there was no 
change in the repeat distances between the lipid lamellae for PG treated skin. The authors also 
concluded that PG may be incorporated into the head group regions without changing the repeat 
distances between the lipid lamellae rather than intercalating in the lipid bilayers. Brinkmann 
and Müller-Goymann (2005) also suggested that PG may increase the mobility of actives and 
excipients in the lipid lamellae. 
The presence of PG increased not only the permeation of methadone but also the 
permeation of TC. The increased skin uptake of TC may increase further the permeation of 
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methadone by changing the skin environment for percutaneous absorption. Figure 8 compares 
the permeation profiles of methadone, PG and TC in human skin. A good correlation (r2 = 
0.97) between the amount of methadone and TC permeated at 24 h was observed.  The results 
suggest that the permeation of methadone followed the permeation of TC closely.
A further potential mechanism of the penetration enhancement of PG on basic drugs is 
also hypothesised. Skin lipids are mainly composed of various types of ceramides, free fatty 
acids, cholesterol and cholesteryl sulphate (Marjukka Suhonen et al., 1999; Walters and 
Roberts, 2002). The free fatty acids in the epidermis may interact with basic drugs such as 
methadone, rivastigmine and fentanyl. Therefore, the free base forms of these drugs may be 
converted to the less hydrophobic protonated forms which are generally less permeable 
compared with free base forms. Reports in the literature suggest that PG can react with free 
fatty acids under specific in vitro conditions (Shaw and Lo, 1994; Shaw et al., 2003). Therefore, 
it is possible that the presence of PG may enhance the permeation of methadone by interacting 
with the carboxyl group of fatty acids in skin. Recent studies have also revealed the important 
role of skin microbiota in skin lipid composition and barrier function (Myles et al., 2016; Chen 
et al., 2018; Niehues et al., 2018). Further investigations of potential skin microbiota 
involvement in the interactions between the carboxyl group of free fatty acids and the hydroxyl 
group of PG in skin are necessary in order to clarify this possibility.
4. Conclusions
The effects of binary and ternary systems on the dermal delivery of methadone were 
investigated in this proof-of-concept study. Enhanced skin permeation was observed for all 
formulations tested, compared with previous work, especially for formulations incorporating 
both PG and TC. The maximum skin flux obtained for permeation studies in porcine skin and 
human skin was 13.58 ± 4.16 and 3.57 ± 0.48 μg/cm2/h, respectively. Although methadone free 
base has poor solubility in PG, the presence of PG in binary systems with TC appears to play 
an important role in the delivery of the molecule. The mechanisms for the synergistic action of 
PG and TC were explored by monitoring the permeation of both solvents. TC was proposed as 
a good “carrier-solvent” for methadone and results from the present work confirm that the 
permeation of methadone appears to “track” the permeation of TC. Solvent uptake studies show 
that the presence of PG in binary formulations increased not only the permeation of methadone 
but also the skin uptake of TC. Further investigation of the biochemical reactions between PG 
and free fatty acids in the skin is required to understand any potential mechanisms of PG in 
vivo. This study should contribute to the development of novel dermal formulations for 
13
methadone and will ultimately provide alternative approaches for management of pain. Other 
techniques to study the synergistic actions of PG and TC at the molecular level, for example, 
confocal Raman spectroscopy, should also allow a better understanding of their residence time 
and effects on the skin. 
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Figure 1. Percent of the applied weight of 5% (w/v) methadone free base solutions remaining 
over 24 h under static condition (32 ± 1 °C and 50 ± 1.5% RH) (mean ± SD; n=3). 
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Figure 2. Permeation profiles of methadone in porcine ear skin after application of 5% (w/v) 
methadone free base in LIM (), LIM:EO (50:50) (), LIM:TC (50:50) (), LIM:OSAL 
(50:50) (×), EO:TC (50:50) (), EO:OSAL (50:50) () and PG:TC (50:50) () for finite dose 
(5 μL/cm2) at 32 ± 1 °C (mean ± SD; 4 ≤ n ≤ 5).
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Figure 3. Permeation profiles of methadone in porcine ear skin after application of 5% (w/v) 
methadone free base in PG:TC (25:75) (×), PG:TC (50:50) () and PG:TC (75:25) () for 
finite dose (5 μL/cm2) at 32 ± 1 °C (mean ± SD; 4 ≤ n ≤ 5).
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Figure 4. Permeation profiles of methadone in porcine ear skin after application of 5% (w/v) 
methadone free base in TC (), PG:TC (50:50) (), PG:TC:IPA (40:40:20) (), PG:TC:IPA 
(30:30:40)  (×), PG:TC:LIM (25:70:5) (), PG:TC:LIM (45:50:5)  () and PG:TC:LIM 
(65:30:5) () for finite dose (5 μL/cm2) at 32 ± 1 °C (mean ± SD; 4 ≤ n ≤ 5).
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Figure 5. Permeation profiles of methadone in human skin after application of 5% (w/v) 
methadone free base in TC (), PG:TC (25:75) (), PG:TC (50:50) (), PG:TC:IPA 
(40:40:20) (×), PG:TC:IPA (30:30:40) () and LIM:TC (50:50) () for finite dose (5 μL/cm2) 
at 32 ± 1 °C (mean ± SD; 4 ≤ n ≤ 5).
21
Figure 6. Correlation between the percentage of applied methadone permeated through human 
skin and porcine skin after 24 h (mean ± SD; 4 ≤ n ≤ 5).
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Figure 7. Permeation profiles for solvent uptake in porcine skin and human skin after 
application of 5% (w/v) methadone free base in PG:TC (25:75) (), PG:TC (50:50) (), 
PG:TC (75:25) (), TC () finite doses (5 μL/cm2) at 32 ± 1 °C (mean ± SD; n = 4).
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Figure 8. Comparison of permeation profiles of methadone (), PG () and TC () in human 
skin under finite dose conditions (5 μL/cm2) at 32 ± 1 °C (mean ± SD; n = 4). The 5% w/v 
methadone base formulations applied were prepared in (A) neat TC, (B) PG:TC (25:75) and 
(C) PG:TC (50:50). (D) Relationship between the percentages of methadone and TC permeated 
at 24 h.
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Highlights
• A good correlation (r2 = 0.80) for methadone permeation was obtained between porcine 
ear skin and human skin
• Propylene glycol increased the skin permeation of Transcutol® in porcine skin and 
human skin
• Synergistic actions between propylene glycol and Transcutol® on the penetration 
enhancement of methadone were observed
• Methadone appears to “track” the permeation of Transcutol®
